# Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

> **NCT01166477** · PHASE4 · COMPLETED · sponsor: **Sociedad Andaluza de Enfermedades Infecciosas** · enrollment: 228 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Lopinavir and ritonavir
- **DRUG:** Triple therapy with ritonavir

## Key facts

- **NCT ID:** NCT01166477
- **Lead sponsor:** Sociedad Andaluza de Enfermedades Infecciosas
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2013-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166477, "Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01166477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*